gamma-secretase-activating protein; GSAP; protein pigeon homolog; GSAP-16K (GSAP, PION, LOC392943)
Jump to navigation
Jump to search
Function
- regulator of gamma-secretase activity
- specifically activates the production of beta-amyloid protein (beta-amyloid protein 40 & beta-amyloid protein 42), without affecting the cleavage of other gamma-secretase targets such as notch.
- specifically promotes the gamma-cleavage of APP CTF-alpha (C-terminal fragment of APP after beta secretase cleavage) to generate beta-amyloid
- reduces the epsilon-cleavage of APP CTF-alpha, leading to low production of AICD
- GSAP is first synthesized as a holoprotein form of 98 kD & rapidly processed into the gamma-secretase-activating protein 16 kD C-terminal form, which constitutes the predominant form
- interacts with APP; specifically interacts with the CTF-alpha product of APP
- interacts with the gamma-secretase complex
Structure
belongs to the GSAP family
Compartment
Golgi apparatus, trans-Golgi network
Alternative splicing
named isoforms=4
Expression
widely expressed
Pharmacology
- activity is specifically inhibited by imatinib (Gleevec)
- imatinib binds PION/GSAP & acts by preventing PION/GSAP interaction with the gamma-secretase substrate, APP CTF-alpha (C-terminal fragment of APP after beta secretase cleavage)
- thus imatinib may inhibit beta-amyloid production[2]
More general terms
References
- ↑ UniProt http://www.uniprot.org/uniprot/A4D1B5.html
- ↑ 2.0 2.1 He G, Luo W, Li P, Remmers C Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease. Nature. 2010 Sep 2;467(7311):95-8 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20811458